MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

318 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q3 2018.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 278 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 75,541,156 shares of 93,104,451 outstanding shares and own 81% of the company stock.
Largest 10 shareholders include BlackRock Inc. (11,466,610 shares), BAILLIE GIFFORD & CO (9,547,193 shares), Vanguard Group Inc (8,656,933 shares), D. E. Shaw & Co., Inc. (3,892,978 shares), STATE STREET CORP (3,448,412 shares), DIMENSIONAL FUND ADVISORS LP (2,642,281 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (2,575,754 shares), ACADIAN ASSET MANAGEMENT LLC (2,387,166 shares), Thrivent Financial for Lutherans (2,372,526 shares), and NORTHERN TRUST CORP (1,658,013 shares).
This table shows the top 278 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.